Woodstock Corp Sells 48 Shares of Stryker Co. (NYSE:SYK)

Woodstock Corp trimmed its holdings in Stryker Co. (NYSE:SYKFree Report) by 0.3% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,699 shares of the medical technology company’s stock after selling 48 shares during the quarter. Woodstock Corp’s holdings in Stryker were worth $4,790,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Quarry LP acquired a new position in shares of Stryker during the first quarter valued at $27,000. Freedom Wealth Alliance LLC acquired a new position in Stryker during the 4th quarter valued at about $26,000. Altshuler Shaham Ltd acquired a new position in Stryker during the 1st quarter valued at about $33,000. HBW Advisory Services LLC bought a new position in shares of Stryker in the 2nd quarter valued at about $35,000. Finally, Elequin Securities LLC acquired a new stake in shares of Stryker during the 4th quarter worth approximately $29,000. 76.24% of the stock is owned by institutional investors.

Insider Buying and Selling at Stryker

In other Stryker news, insider Viju Menon sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $289.00, for a total value of $1,445,000.00. Following the completion of the transaction, the insider now directly owns 6,994 shares in the company, valued at $2,021,266. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 5.90% of the company’s stock.

Analyst Ratings Changes

SYK has been the subject of a number of recent research reports. Argus boosted their price target on shares of Stryker from $285.00 to $310.00 in a research note on Thursday, May 25th. StockNews.com downgraded shares of Stryker from a “buy” rating to a “hold” rating in a research note on Friday, September 8th. Bank of America upgraded Stryker from a “neutral” rating to a “buy” rating and upped their price objective for the company from $310.00 to $315.00 in a report on Tuesday, September 5th. Barclays upped their price objective on Stryker from $321.00 to $335.00 and gave the company an “overweight” rating in a report on Monday, August 7th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $325.00 target price on shares of Stryker in a research note on Thursday, August 17th. Six investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $309.59.

Get Our Latest Stock Analysis on SYK

Stryker Stock Up 0.1 %

Shares of NYSE:SYK traded up $0.24 during mid-day trading on Friday, reaching $295.24. 307,944 shares of the stock were exchanged, compared to its average volume of 1,291,198. The company has a quick ratio of 0.84, a current ratio of 1.54 and a debt-to-equity ratio of 0.64. The company has a market cap of $112.13 billion, a P/E ratio of 41.67, a P/E/G ratio of 2.87 and a beta of 0.95. Stryker Co. has a one year low of $200.80 and a one year high of $306.93. The stock’s 50 day simple moving average is $286.93 and its 200-day simple moving average is $285.36.

Stryker (NYSE:SYKGet Free Report) last posted its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.38 by $0.16. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.83 billion. Stryker had a return on equity of 22.31% and a net margin of 13.92%. Stryker’s quarterly revenue was up 11.2% on a year-over-year basis. During the same period last year, the company earned $2.25 earnings per share. As a group, equities research analysts predict that Stryker Co. will post 10.37 EPS for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be paid a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.00 dividend on an annualized basis and a yield of 1.02%. Stryker’s dividend payout ratio is 42.37%.

Stryker Company Profile

(Free Report)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies.

Read More

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYKFree Report).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.